Likewise, treatment with docetaxel upregulates miR-140 expression in prostate cancer cells, and miR-140 can directly bind to the 3′-untranslated region of OGT mRNA to suppress its expression, thereby enhancing the drug sensitivity of PC cells to docetaxel (Fig. 3) [101]. Here, OGT is linked to prostate cancer.